We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-20.33%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.4%
AUM
$12B
AUM Growth
-$2.98B
Cap. Flow
+$613M
Cap. Flow %
5.11%
Top 10 Hldgs %
28.69%
Holding
863
New
191
Increased
291
Reduced
251
Closed
118

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$150M
2
DGX icon
Quest Diagnostics
DGX
+$142M
3
USB icon
US Bancorp
USB
+$135M
4
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$130M
5
SBUX icon
Starbucks
SBUX
+$103M

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$151M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$99.6M
3
BKNG icon
Booking.com
BKNG
+$96.9M
4
HUM icon
Humana
HUM
+$96.4M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$89.7M

Sector Composition

Rank Sector Weight
1 Technology 24.61%
2 Healthcare 19.51%
3 Financials 13.3%
4 Consumer Discretionary 10.41%
5 Communication Services 8.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BWA icon
251
BorgWarner
BWA
$13.7B
$4.69M 0.04%
218,532
+73,071
+50% +$2.11M
BLMN icon
252
Bloomin' Brands
BLMN
$1.01B
$4.68M 0.04%
656,084
+92,800
+16% +$1.62M
DAN icon
253
Dana Inc
DAN
$3.01B
$4.64M 0.04%
594,097
-311,036
-34% -$4.29M
SPOK icon
254
Spok Holdings
SPOK
$235M
$4.63M 0.04%
433,278
-26,710
-6% -$287K
BMY.RT
255
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$4.6M 0.04%
1,211,450
+460,375
+61% +$1.52M
HVT icon
256
Haverty Furniture Companies
HVT
$465M
$4.59M 0.04%
386,142
-25,884
-6% -$455K
TCBK icon
257
TriCo Bancshares
TCBK
$1.85B
$4.57M 0.04%
153,080
-34,920
-19% -$1.22M
PGR icon
258
Progressive
PGR
$124B
$4.56M 0.04%
61,738
-16,249
-21% -$1.25M
SCS
259
DELISTED
Steelcase
SCS
$4.49M 0.04%
455,302
+274,418
+152% +$4.53M
ECPG icon
260
Encore Capital Group
ECPG
$1.99B
$4.43M 0.04%
189,400
+137,100
+262% +$4.61M
KBAL
261
DELISTED
Kimball International
KBAL
$4.35M 0.04%
365,600
+89,500
+32% +$1.49M
AVT icon
262
Avnet
AVT
$7.97B
$4.35M 0.04%
173,367
+151,429
+690% +$5.16M
CBZ icon
263
CBIZ
CBZ
$2.97B
$4.34M 0.04%
207,471
+182,185
+720% +$4.64M
AMZN icon
264
Amazon
AMZN
$2.94T
$4.33M 0.04%
44,460
+20,120
+83% +$1.95M
DSPG
265
DELISTED
DSP Group Inc
DSPG
$4.26M 0.04%
318,200
+81,647
+35% +$1.17M
EGOV
266
DELISTED
NIC Inc
EGOV
$4.26M 0.04%
185,075
+85,600
+86% +$1.75M
TEL icon
267
TE Connectivity
TEL
$63.2B
$4.22M 0.04%
67,036
+21,815
+48% +$1.86M
PFC
268
DELISTED
Premier Financial Corp. Common Stock
PFC
$4.22M 0.04%
286,324
+66,124
+30% +$1.68M
ENTA icon
269
Enanta Pharmaceuticals
ENTA
$384M
$4.18M 0.03%
+81,300
New +$4.33M
ALL icon
270
Allstate
ALL
$68.1B
$4.14M 0.03%
45,084
+6,482
+17% +$705K
CNMD icon
271
CONMED
CNMD
$1.48B
$4.1M 0.03%
+71,600
New +$6.6M
RARX
272
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$4.08M 0.03%
+85,050
New +$3.96M
IMKTA icon
273
Ingles Markets
IMKTA
$1.67B
$4.08M 0.03%
112,762
-5,400
-5% -$214K
EFC
274
Ellington Financial
EFC
$1.66B
$4.04M 0.03%
706,700
+350,000
+98% +$5.45M
SPGI icon
275
S&P Global
SPGI
$121B
$4.03M 0.03%
+16,430
New +$4.51M
9 10
11
12 13

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2020 Portfolio in Review

As of Q1 2020, Grantham, Mayo, Van Otterloo & Co (GMO) held 863 positions worth $12B, down 20% from $15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $613M of net new capital in Q1 2020, opening 191 new positions and adding to 291 existing holdings. Its largest new stake was Quest Diagnostics: 1,373,100 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $99.6M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2020 buy was Quest Diagnostics: 1,373,100 shares worth $110M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Coca-Cola in Q1 2020, an estimated $150M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2020 reduction was Alphabet (Google) Class C, cutting an estimated $99.6M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Mastercard in Q1 2020, selling an estimated $151M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 29% of its $12B portfolio in Q1 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 191 new positions and closed 118 in Q1 2020.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 20% quarter-over-quarter to $12B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2020, filed 14 May 2020.